Identifying Chinese herbal medicine for premenstrual syndrome: implications from a nationwide database

BMC Complementary and Alternative Medicine

Yu-Chun Chen⁵  Jen-Wu Huang¹  Jiun-Liang Chen⁴  Sien-Hung Yang⁴  Irene H Su³  Yi-Hsuan Lin⁴  Ben-Shian Huang²  Hsing-Yu Chen⁴ 

[1]Department of Surgery, National Yang-Ming University Hospital, I-Lan, Taiwan

[2]School of Medicine, National Yang-Ming University, Taipei, Taiwan

[3]Department of Reproductive Medicine, University of California, La Jolla, San Diego, CA, USA

[4]School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan

[5]Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan

关键词: Traditional Chinese medicine;    Social network analysis;    National health insurance research database;    Association rule mining;    Premenstrual syndrome;    Chinese herbal medicine;   

Others  :  1220086
DOI  :  10.1186/1472-6882-14-206

 received in 2014-03-27, accepted in 2014-06-24,  发布年份 2014

【 摘 要 】

Background

Premenstrual syndrome (PMS) occurs in women during their reproductive age with a quite negative impact on their daily lives. Women with PMS experience a wide range of physical or psychological symptoms and seek treatment for them. Chinese herb medicine (CHM) is commonly used for PMS and the goal of this study is to investigate the prescription patterns of CHM for PMS by using a nationwide database.

Methods

Prescriptions of CHM were obtained from two million beneficiaries randomly sampled from the National Health Insurance Research Database, a nationwide database in Taiwan. The ICD-9 code 625.4 was used to identify patients with PMS. Association rule mining and social network analysis were used to explore both the combinations and the core treatments for PMS.

Results

During 1998-2011, a total of 14,312 CHM prescriptions for PMS were provided. Jia-Wei-Xiao-Yao-San (JWXYS) was the CHM which had the highest prevalence (37.5% of all prescriptions) and also the core of prescription network for PMS. For combination of two CHM, JWXYS with Cyperus rotundus L. was prescribed most frequently, 7.7% of all prescriptions, followed by JWXYS with Leonurus heterophyllus Sweet, 5.9%, and Cyperus rotundus L. with Leonurus heterophyllus Sweet, 5.6%.

Conclusions

JWXYS-centered CHM combinations were most commonly prescribed for PMS. To the best of our knowledge, this is the first pharmaco-epidemiological study to review CHM treatments for PMS. However, the efficacy and safety of these commonly used CHM were still lacking. The results of this study provide valuable references for further clinical trials and bench studies.

【 授权许可】

   
2014 Chen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Yonkers KA, O’Brien PM, Eriksson E: Premenstrual syndrome. Lancet 2008, 371:1200-1210.
• [2]Hartlage SA, Freels S, Gotman N, Yonkers K: Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets. Arch Gen Psychiatry 2012, 69:300-305.
• [3]Campbell EM, Peterkin D, O’Grady K, Sanson-Fisher R: Premenstrual symptoms in general practice patients. Prevalence and treatment. J Reprod Med 1997, 42:637-646.
• [4]Borenstein J, Chiou CF, Dean B, Wong J, Wade S: Estimating direct and indirect costs of premenstrual syndrome. J Occup Environ Med 2005, 47:26-33.
• [5]Halbreich U, Borenstein J, Pearlstein T, Kahn LS: The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003, 28(Suppl 3):1-23.
• [6]Rapkin AJ, Winer SA: Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res 2009, 9:157-170.
• [7]Rapkin AJ, Edelmuth E, Chang LC, Reading AE, McGuire MT, Su TP: Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 1987, 70:533-537.
• [8]Freeman EW, Rickels K, Sondheimer SJ, Polansky M: A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 1995, 274:51-57.
• [9]Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM: Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 2003, 54:757-762.
• [10]Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR: Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998, 338:209-216.
• [11]Wyatt K, Dimmock P, Jones P, Obhrai M, O’Brien S: Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 2001, 323:776-780.
• [12]Rickels K, Freeman E, Sondheimer S: Buspirone in treatment of premenstrual syndrome. Lancet 1989, 1:777.
• [13]Marjoribanks J, Brown J, O'Brien PMS, Wyatt K: Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2013, (6):CD001396. doi:10.1002/14651858.CD001396.pub3
• [14]Hu XH, Bull SA, Hunkeler EM, Ming E, Lee JY, Fireman B, Markson LE: Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004, 65:959-965.
• [15]Jing Z, Yang X, Ismail KMK, Chen XY, Wu T: Chinese herbal medicine for premenstrual syndrome. Cochrane Database Syst Rev 2009, (1):CD006414. doi:10.1002/14651858.CD006414.pub2
• [16]Kim SY, Park HJ, Lee H, Lee H: Acupuncture for premenstrual syndrome: a systematic review and meta-analysis of randomised controlled trials. BJOG 2011, 118:899-915.
• [17]Jang S, Kim D, Choi MS: Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complement Altern Med 2014, 14:11.
• [18]Chang LC, Huang N, Chou YJ, Lee CH, Kao FY, Huang YT: Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv Res 2008, 8:170.
• [19]Yang SH, Chen HY, Lin YH, Chen YC: The Exploration of Disease Pattern, Zheng, for Differentiation of Allergic Rhinitis in Traditional Chinese Medicine Practice. Evid Based Complement Alternat Med 2012, 2012:7.
• [20]Chen HY, Lin YH, Su IH, Chen YC, Yang SH, Chen JL: Investigation on Chinese herbal medicine for primary dysmenorrhea: implication from a nationwide prescription database in Taiwan. Complement Ther Med 2014, 22:116-125.
• [21]Lin YH, Chen YC, Hu S, Chen HY, Chen JL, Yang SH: Identifying core herbal treatments for urticaria using Taiwan’s nationwide prescription database. J Ethnopharmacol 2013, 148:556-562.
• [22]Chen HY, Lin YH, Thien PF, Chang SC, Chen YC, Lo SS, Yang SH, Chen JL: Identifying core herbal treatments for children with asthma: implication from a chinese herbal medicine database in Taiwan. Evid Based Complement Alternat Med 2013, 2013:125943.
• [23]Li J, Lu C, Jiang M, Niu X, Guo H, Li L, Bian Z, Lin N, Lu A: Traditional chinese medicine-based network pharmacology could lead to new multicompound drug discovery. Evid Based Complement Alternat Med 2012, 2012:149762.
• [24]Chen HY, Lin YH, Wu JC, Chen YC, Yang SH, Chen JL, Chen TJ: Prescription patterns of Chinese herbal products for menopausal syndrome: analysis of a nationwide prescription database. J Ethnopharmacol 2011, 137:1261-1266.
• [25]Chen HY, Lin YH, Wu JC, Chen YC, Thien PF, Chen TJ, Yang SH, Chen JL, Lo SS: Characteristics of pediatric traditional Chinese medicine users in Taiwan: a nationwide cohort study. Pediatrics 2012, 129:e1485-1492.
• [26]Dickerson LM, Mazyck PJ, Hunter MH: Premenstrual syndrome. Am Fam Physician 2003, 67:1743-1752.
• [27]Johnson SR: Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstet Gynecol 2004, 104:845-859.
• [28]Gao Y, Liu Z, Wang CJ, Fan XS, Xie JY: Chinese medicine formula network analysis for core herbal discovery. Brain Informatics 2012, 7670:255-264.
• [29]Tai YM, Chiu HW: Comorbidity study of ADHD: applying association rule mining (ARM) to National Health Insurance Database of Taiwan. Int J Med Inf 2009, 78:e75-83.
• [30]Zhang Y, Han M, Liu Z, Wang J, He Q, Liu J: Chinese herbal formula xiao yao san for treatment of depression: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2012, 2012:931636.
• [31]Qin F, Huang X, Ren P: Chinese herbal medicine modified xiaoyao san for functional dyspepsia: meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2009, 24:1320-1325.
• [32]Hsiao MC, Liu CY, Chen KC, Hsieh TT: Characteristics of women seeking treatment for premenstrual syndrome in Taiwan. Acta Psychiatr Scand 2002, 106:150-155.
• [33]Yazdanparast R, Ardestani A: In vitro antioxidant and free radical scavenging activity of Cyperus rotundus. J Med Food 2007, 10:667-674.
• [34]Kilani S, Ledauphin J, Bouhlel I, Ben Sghaier M, Boubaker J, Skandrani I, Mosrati R, Ghedira K, Barillier D, Chekir-Ghedira L: Comparative study of Cyperus rotundus essential oil by a modified GC/MS analysis method. Evaluation of its antioxidant, cytotoxic, and apoptotic effects. Chem Biodivers 2008, 5:729-742.
• [35]Matkowski A, Piotrowska M: Antioxidant and free radical scavenging activities of some medicinal plants from the Lamiaceae. Fitoterapia 2006, 77:346-353.
• [36]Henkes H, Franz M, Kendall O, Monroe J, Legaspi A, LeDoux J, Haese C, Williams D, McCall S, Johnson AD, Ceremuga TE: Evaluation of the anxiolytic properties of tetrahydropalmatine, a Corydalis yanhusuo compound, in the male Sprague-Dawley rat. AANA J 2011, 79:S75-80.
• [37]Cao FL, Shang GW, Wang Y, Yang F, Li CL, Chen J: Antinociceptive effects of intragastric dl-tetrahydropalmatine on visceral and somatic persistent nociception and pain hypersensitivity in rats. Pharmacol Biochem Behav 2011, 100:199-204.
• [38]Imanshahidi M, Hosseinzadeh H: The pharmacological effects of Salvia species on the central nervous system. Phytother Res 2006, 20:427-437.
• [39]Feng Y, You Z, Yan S, He G, Chen Y, Gou X, Peng C: Antidepressant-like effects of salvianolic acid B in the mouse forced swim and tail suspension tests. Life Sci 2012, 90:1010-1014.
• [40]Isacchi B, Fabbri V, Galeotti N, Bergonzi MC, Karioti A, Ghelardini C, Vannucchi MG, Bilia AR: Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. Eur J Pharm Sci 2011, 44:552-558.
• [41]Zhang YA, Li X, Wang ZZ: Antioxidant activities of leaf extract of Salvia miltiorrhiza Bunge and related phenolic constituents. Food Chem Toxicol 2010, 48:2656-2662.
• [42]Sun S, Yin Y, Yin X, Cao F, Luo D, Zhang T, Li Y, Ni L: Anti-nociceptive effects of Tanshinone IIA (TIIA) in a rat model of complete Freund’s adjuvant (CFA)-induced inflammatory pain. Brain Res Bull 2012, 88:581-588.
• [43]Luo J, Tian C, Xu J, Sun Y: Studies on the antioxidant activity and phenolic compounds of enzyme-assisted water extracts from Du-zhong (Eucommia ulmoides Oliv.) leaves. J Enzyme Inhib Med Chem 2009, 24:1280-1287.
• [44]Park SA, Choi MS, Jung UJ, Kim MJ, Kim DJ, Park HM, Park YB, Lee MK: Eucommia ulmoides Oliver leaf extract increases endogenous antioxidant activity in type 2 diabetic mice. J Med Food 2006, 9:474-479.
• [45]Park SW, Kim YK, Lee JG, Kim SH, Kim JM, Yoon JS, Park YK, Lee YK, Kim YH: Antidepressant-like effects of the traditional Chinese medicine kami-shoyo-san in rats. Psychiatry Clin Neurosci 2007, 61:401-406.
• [46]Oh JK, Kim Y-S, Park H-J, Lim E-M, Pyun K-H, Shim I: Antidepressant effects of Soyo-san on immobilization stress in ovariectomized female rats. Biol Pharm Bull 2007, 30:1422-1426.
• [47]Yasui T, Yamada M, Uemura H, Ueno S, Numata S, Ohmori T, Tsuchiya N, Noguchi M, Yuzurihara M, Kase Y, Irahara M: Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine. Maturitas 2009, 62:146-152.
• [48]Toriizuka K, Kamiki H, Ohmura NY, Fujii M, Hori Y, Fukumura M, Hirai Y, Isoda S, Nemoto Y, Ida Y: Anxiolytic effect of Gardeniae Fructus-extract containing active ingredient from Kamishoyosan (KSS), a Japanese traditional Kampo medicine. Life Sci 2005, 77:3010-3020.
• [49]Park HJ, Shim HS, Chung SY, Lee TH, Shim I: Soyo-san reduces depressive-like behavior and proinflammatory cytokines in ovariectomized female rats. BMC Complement Altern Med 2014, 14:34.
• [50]Xu F, Peng D, Tao C, Yin D, Kou J, Zhu D, Yu B: Anti-depression effects of Danggui-Shaoyao-San, a fixed combination of Traditional Chinese Medicine, on depression model in mice and rats. Phytomedicine 2011, 18:1130-1136.
• [51]Stefek M, Benes L: In vitro studies on the activity of japanese kampo herbal medicines Oren-Gedoku-To (TJ-15) and Toki-Shakuyaku-San (TJ-23) as scavengers of free radicals. Drug Metabol Drug Interact 1994, 11:25-36.
• [52]Koike K, Ohno S, Takahashi N, Suzuki N, Nozaki N, Murakami K, Sugiura K, Yamada K, Inoue M: Efficacy of the herbal medicine Unkei-to as an adjunctive treatment to hormone replacement therapy for postmenopausal women with depressive symptoms. Clin Neuropharmacol 2004, 27:157-162.
• [53]Duvan CI, Cumaoglu A, Turhan NO, Karasu C, Kafali H: Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet 2011, 283:299-304.
• [54]Scheid V: Traditional Chinese medicine–what are we investigating? The case of menopause. Complement Ther Med 2007, 15:54-68.
• [55]Chini F, Pezzotti P, Orzella L, Borgia P, Guasticchi G: Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sources. BMC Public Health 2011, 11:688.
• [56]Zhang LD, Zhang YL, Xu SH, Zhou G, Jin SB: Traditional Chinese medicine typing of affective disorders and treatment. Am J Chin Med 1994, 22:321-327.
• [57]Scheid V: Depression, constraint, and the liver: (dis)assembling the treatment of emotion-related disorders in Chinese medicine. Cult Med Psychiatry 2013, 37:30-58.
• [58]Scheid V, Ward T, Tuffrey V: Comparing TCM textbook descriptions of menopausal syndrome with the lived experience of London women at midlife and the implications for Chinese medicine research. Maturitas 2010, 66:408-416.